Quebec innovation in the life sciences, supported by players such as IRICoR, plays a vital role in improving the quality of life of patients and makes a significant contribution to meeting the challenges facing the healthcare system.
Read about IRICoR in the special Research section of Le Devoir – BIS.
Among other things, the article highlights the importance of […]
On February 21, Elizabeth Douville, PhD, ICD.D, President and CEO of the organization, will be a panelist at the event “𝘏𝘰𝘸 𝘤𝘢𝘯 𝘘𝘶𝘦𝘣𝘦𝘤 𝘣𝘦𝘤𝘰𝘮𝘦 𝘢 𝘨𝘭𝘰𝘣𝘢𝘭 𝘭𝘦𝘢𝘥𝘦𝘳 𝘪𝘯 𝘓𝘪𝘧𝘦 𝘚𝘤𝘪𝘦𝘯𝘤𝘦 𝘪𝘯𝘯𝘰𝘷𝘢𝘵𝘪𝘰𝘯? “, organized by the Conseil des relations internationales de Montréal (CORIM).
This discussion between Gordon McCauley (adMare BioInnovations), Stefan Raos (Moderna), Lloyd Mitchell Segal (
IRICoR will attend the AUTM Annual Meeting, February 18-21, 2024.
AUTM’s Annual Meeting invites technology transfer professionals from around the globe to network, make deals and gain valuable insights from world-class speakers and panels.
If you would like to meet with IRICoR at AUTM 2024, please contact Jean-louis Brochu, M.Sc., Director Intellectual property and communication or Narjes Achach, Intellectually property Analyst, who […]
Narjes Achach, PharmD, LLM, Intellectual Property Analyst at IRICoR, took up pen to write a brilliant and insightful articleon the Equity, Diversity and Inclusion in the AUTM newsletter.
What can we do to keep the discussion open and move forward as a society and individual?
💡 3 words : Educate / Engage / Endure
“In this column we often […]
IRICoR will attend the 29th Annual International Partnering Conference BIO-Europe. This conference is being held from November 6 to November 8, 2023 in Munich, Germany.
This industry event aims to create business opportunities between life science players from around the world. It is also an opportunity for companies and institutions to develop partnerships of interest with complementary organizations, notably by presenting […]
By linking academia with industry and financial partners, and through its special relationship with IRIC, IRICoR has been innovating for nearly 15 years in the way it transforms drug discoveries into therapies for the benefit of patients.
IRICoR is proud to have collaborated on the XTRA La Presse+ edition – Montreal: a hub of health and innovation.
Through an interview with Elizabeth […]
The new issue of BIOTECanada’s Insights magazine is now available. IRICoR is proud to have collaborated on this edition. Find an article in Q&A format with IRICoR partner, Ipsen, highlighting the importance of collaboration in life sciences to optimize research and to effectively integrate innovations into the health system.
To read the full article, click
IRICoR announces its participation in the BIO 2023 international convention to be held from June 5 to 8, 2023 in Boston. This industry event aims to create business opportunities among life science players from all over the world. It is also an opportunity for companies and institutions to develop partnerships of interest with complementary organizations, in particular through the presentation […]
Montreal, February 27, 2023 – The members of IRICoR’s Board of Directors are proud today to announce the appointment of Elizabeth Douville, Ph.D., ICD.D, to the position of President and Chief Executive Officer of the organization. This appointment comes after Dr. Nadine Beauger, Ph.D., MBA, informed the members of the Board of Directors of her decision to leave the position […]
Ipsen, UdeM and IRICoR broaden existing oncology partnership, with an exclusive license agreement and two new discovery-stage programs
PARIS, FRANCE, MONTREAL, CANADA 15 February 2023 – Ipsen (Euronext: IPN; ADR: IPSEY), Université de Montréal and IRICoR announce that Ipsen has exercised its option to acquire exclusive rights to a pre-clinical stage program with potential oncology applications. This license agreement is the result of a fruitful collaboration established between Ipsen, Université de Montréal and IRICoR in May 2020. Ipsen […]